Metaphedrine

Metaphedrine
Legal status
Legal status
Identifiers
  • N-methyl-1-(3-methylphenyl)propan-2-amine
CAS Number
PubChem CID
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC11H17N
Molar mass163.264 g·mol−1
3D model (JSmol)
  • CC1=CC(=CC=C1)CC(C)NC
  • InChI=1S/C11H17N/c1-9-5-4-6-11(7-9)8-10(2)12-3/h4-7,10,12H,8H2,1-3H3
  • Key:CXVNKBVJDKMLOH-UHFFFAOYSA-N

3-Methylmethamphetamine (3-MMA) or Metaphedrine is an amphetamine derivative which has been sold as a designer drug, first being reported in Sweden in 2021.[1] It is a potent monoamine reuptake inhibitor.[2] The drug was not active as a serotonin 5-HT2A receptor agonist.[2]

See also

References

  1. ^ European Monitoring Centre for Drugs and Drug Addiction. (June 2022). New psychoactive substances: 25 years of early warning and response in Europe. An update from the EU Early Warning System (PDF). European Monitoring Centre for Drugs and Drug Addiction. doi:10.2810/882318 (inactive 12 July 2025). ISBN 978-92-9497-737-3.{{cite book}}: CS1 maint: DOI inactive as of July 2025 (link)
  2. ^ a b Stalberga D, Kronstrand R, Schranz B, van Zijl N, Karlman S, Aref S, et al. (2025). "Comprehensive in vitro profiling of traditional and emerging stimulants at monoamine transporters and the 5HT2A receptor". Authorea. doi:10.22541/au.176253891.19158813/v1.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.